Your session is about to expire
← Back to Search
Behavioural Intervention
Cognitive-Somatosensory-Motor Training for Stroke (iCOSMO Trial)
N/A
Recruiting
Led By Mark Bayley, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of motor and/or somatosensory deficits in the upper limbs
Clinical diagnosis of stroke
Must not have
Prior history of central nervous system dysfunction other than stroke
Upper limb deficits resulting from non-stroke pathology
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after intervention,1-month
Awards & highlights
No Placebo-Only Group
Summary
"This trial is looking at whether a new intervention that combines sensation, movement, and thinking can help improve arm and hand function in people who have had a stroke a long time ago."
Who is the study for?
The iCOSMO trial is for individuals who have had a stroke and are looking to improve the function of their arm and hand. Specific eligibility criteria details were not provided.
What is being tested?
This study tests two types of training programs: GRASP, which patients do at home, and iCOSMO, which integrates sensory, motor, and cognitive exercises to aid recovery after a chronic stroke.
What are the potential side effects?
Potential side effects are not detailed in the information provided but may include muscle soreness or fatigue due to exercise-based interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have weakness or sensory loss in my arms.
Select...
I have been diagnosed with a stroke.
Select...
I am over 18 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a brain disorder other than a stroke.
Select...
I have arm or hand issues not caused by a stroke.
Select...
I can follow instructions and provide consent for treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, immediately after intervention,1-month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after intervention,1-month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Action Research Arm Test (ARAT)
Box and Block Test (BBT)
Fidelity
+14 moreSecondary study objectives
Pain visual analogue scale (PVAS)
Stanford Fatigue Visual Analogue Scale (SFVAS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: iCOSMOExperimental Treatment1 Intervention
20 participants will receive the iCOSMO intervention. iCOSMO consists of two training approaches that will include active touch and movement exploratory procedures during goal-oriented tasks as well as robotic training using the Kinarm Exoskeleton device.
Group II: Home GRASPActive Control1 Intervention
20 participants will receive the control intervention. The control group will receive a matched dose of a home-based exercise programme. The home-based exercise programme will be based on the Home Graded Repetitive Arm Supplementary Program.
Find a Location
Who is running the clinical trial?
StrokeCog clinical training platformUNKNOWN
University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,282 Total Patients Enrolled
25 Trials studying Stroke
5,571 Patients Enrolled for Stroke
Mark Bayley, MDPrincipal InvestigatorToronto Rehabilitation Institute
6 Previous Clinical Trials
592 Total Patients Enrolled
3 Trials studying Stroke
243 Patients Enrolled for Stroke